CRISPR Therapeutics AG (CRSP) Enterprise Value (2015 - 2026)
CRISPR Therapeutics AG (CRSP) posted Enterprise Value of -$2.4 billion for Q1 2026, down 23.58% sequentially from -$2.0 billion in Q4 2025, and down 31.61% YoY from -$3.6 billion in Q1 2025.
CRISPR Therapeutics AG (CRSP) Enterprise Value (2015 - 2026) Analysis & Trends
CRISPR Therapeutics AG has reported Enterprise Value for 12 years, with the latest figure at -$2.4 billion in Q1 2026.
- Quarterly Enterprise Value fell 31.61% year-over-year to -$2.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.4 billion (down 31.61% YoY) and the FY2025 annual result came in at -$2.0 billion, down 23.06% from the prior year.
- Enterprise Value eased to -$2.4 billion in Q1 2026 per CRSP's latest filing, from -$2.0 billion in the prior quarter.
- Over five years, Enterprise Value peaked at -$1.6 billion in Q4 2024 and troughed at -$2.4 billion in Q1 2026.
- A 5-year average of -$1.9 billion and a median of -$1.9 billion in 2022 frame the typical range for Enterprise Value.
- The sharpest annual moves came in 2022 and 2026: Enterprise Value gained 23.7% in 2022, then plunged 31.61% in 2026.
- Over 5 years, Enterprise Value stood at -$1.8 billion in 2022, then advanced by 6.7% to -$1.7 billion in 2023, then gained by 5.2% to -$1.6 billion in 2024, then decreased by 23.06% to -$2.0 billion in 2025, then fell by 23.58% to -$2.4 billion in 2026.
- According to Business Quant data, Enterprise Value over the past three periods registered -$2.4 billion, -$2.0 billion, and -$1.9 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | -5.18 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -3.94 Bn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | -5.10 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -8.46 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 2.12 Bn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | -3.31 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -1.16 Bn |
| 10 | CRISPR Therapeutics AG | 5.18 Bn | 5.18 Bn | - | -2.36 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -2.36 Bn |
| Mar 31, 2026 | -2.44 Bn |
| Dec 31, 2025 | -1.98 Bn |
| Sep 30, 2025 | -1.92 Bn |
| Jun 30, 2025 | -1.72 Bn |
| Mar 31, 2025 | -1.86 Bn |
| Dec 31, 2024 | -1.61 Bn |
| Sep 30, 2024 | -1.94 Bn |
| Jun 30, 2024 | -2.00 Bn |
| Mar 31, 2024 | -2.11 Bn |
| Dec 31, 2023 | -1.69 Bn |
| Sep 30, 2023 | -1.74 Bn |
| Jun 30, 2023 | -1.77 Bn |
| Mar 31, 2023 | -1.88 Bn |
| Dec 31, 2022 | -1.82 Bn |
| Sep 30, 2022 | -1.90 Bn |
| Jun 30, 2022 | -2.07 Bn |
| Mar 31, 2022 | -2.22 Bn |
| Dec 31, 2021 | -2.38 Bn |
| Sep 30, 2021 | -2.48 Bn |